4-[3-[(2-amino-3-methoxypropanoyl)amino]-3-[(4-chlorophenyl)methyl]piperidin-1-yl]-3-benzyl-4-oxobutanoic acid
C27H34ClN3O5 — CID 146584193
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[3-[(2-amino-3-methoxypropanoyl)amino]-3-[(4-chlorophenyl)methyl]piperidin-1-yl]-3-benzyl-4-oxobutanoic acid
4-[3-[(2-amino-3-methoxypropanoyl)amino]-3-[(4-chlorophenyl)methyl]piperidin-1-yl]-3-benzyl-4-oxobutanoic acid (PubChem CID 146584193) has the molecular formula C27H34ClN3O5 and a molecular weight of 516.04 g/mol. Its IUPAC name is 4-[3-[(2-amino-3-methoxypropanoyl)amino]-3-[(4-chlorophenyl)methyl]piperidin-1-yl]-3-benzyl-4-oxobutanoic acid.
Molecular Properties
| Compound Name | 4-[3-[(2-amino-3-methoxypropanoyl)amino]-3-[(4-chlorophenyl)methyl]piperidin-1-yl]-3-benzyl-4-oxobutanoic acid |
|---|---|
| PubChem CID | 146584193 |
| Molecular Formula | C27H34ClN3O5 |
| Molecular Weight | 516.04 g/mol |
| Exact Mass | 515.22 |
| IUPAC Name | 4-[3-[(2-amino-3-methoxypropanoyl)amino]-3-[(4-chlorophenyl)methyl]piperidin-1-yl]-3-benzyl-4-oxobutanoic acid |
| SMILES | COCC(N)C(=O)NC1(Cc2ccc(Cl)cc2)CCCN(C(=O)C(CC(=O)O)Cc2ccccc2)C1 |
| InChI | InChI=1S/C27H34ClN3O5/c1-36-17-23(29)25(34)30-27(16-20-8-10-22(28)11-9-20)12-5-13-31(18-27)26(35)21(15-24(32)33)14-19-6-3-2-4-7-19/h2-4,6-11,21,23H,5,12-18,29H2,1H3,(H,30,34)(H,32,33) |
| InChIKey | LOYPCGAMMKWOTP-UHFFFAOYSA-N |
| XLogP | 2.67 |
| TPSA | 121.96 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 516.04 |
| LogP ≤ 5 | 2.67 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146584193 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.